Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

“…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”

eQTL analysis of significant SNPs. by Dai Nogimura (21445649)

Subjects:

Significant associations in the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

Decomposition of changes in the number of CRC burden in East Asian countries, the United States, and globally, 1990–2021. by Yuanyi Cao (22394797)

Subjects:

Period-specific relative risks (RRs) for CRC burden by sex in East Asian countries, the United States, and globally, based on the age-period-cohort model. by Yuanyi Cao (22394797)

Subjects:

Age-specific relative risks (RRs) for CRC burden by sex in East Asian countries, the United States, and globally, based on the age-period-cohort model. by Yuanyi Cao (22394797)

Subjects:

Cohort-specific relative risks (RRs) for CRC burden by sex in East Asian countries, the United States, and globally, based on the age-period-cohort model. by Yuanyi Cao (22394797)

Subjects:

Joinpoint regression analysis of the trends in age-standardised rates of CRC burden in five East Asian countries, the United States, and globally, 1990–2021. by Yuanyi Cao (22394797)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

CD74 regulates tumor progression. by Bianca Pellegrino (20314999)

Primary monocytes at 1 x 10⁶ cells were seeded in a flask and supplemented with RPMI 1640 + GM-CSF + IL-4 and incubated at 37°C for 6 days for monocyte to macrophage tra... by Janani Madhuravasal Krishnan (19736002)

Subjects:

Questionnaire description. by Cristobal Padilla-Fortunatti (21376807)

Subjects:

Table 1_Significance of host antimicrobial peptides in the pathogenesis and treatment of acne vulgaris.docx by Agata Lesiak (17951854)

ROC curve analysis for ERCC1 with CWP progression. by Hao Deng (409186)

Univariate and multivariable analyses for progression free survival. by Huriye Senay Kiziltan (22298378)

Subjects:

Comparison of serum VEGF-A165 concentrations pre-bevacizumab administration in patients with increased VEGF-A post-bevacizumab administration and those with decreased VEGF-A. by Masashi Okawa (8951294)

Subjects: